Mylotarg has potent anti-leukaemic effect: a systematic review and meta-analysis of anti-CD33 antibody treatment in acute myeloid leukaemia.

Ann Hematol · 2015 · PMC4317519 · PMID 25284166

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

GO improves OS in patients with favourable cytogenetic AML (patients with core-binding factor translocations), with borderline significance for those with intermediate-risk cytogenetics.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.